Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Lepage

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|December 5, 2025
Structure-Guided Optimization of Selective Covalent Reversible Peptidomimetic Inhibitors Targeting TMPRSS6Walid Guerrab, Matthieu Lepage, Antoine Désilets, et al.
European Journal of Medicinal Chemistry|November 7, 2025
Structural insights into frog skin-derived cyclic peptides as selective matriptase inhibitorsAgata Gitlin-Domagalska, Malihe Hassanzadeh, Aleksandra Helbik-Maciejewska, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 20, 2025
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potencyAlexandre Joushomme, Antoine Désilets, William Champagne, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potencyAlexandre Joushomme, Antoine Désilets, William Champagne, et al.
Journal of Medicinal Chemistry|July 19, 2024
Rational <i>In Silico</i> Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 SubpocketMichael Desgagné, Antoine Désilets, Sára Ferková, et al.
European Journal of Medicinal Chemistry|May 18, 2025
Optimizing the pharmacokinetics and selectivity of TMPRSS2 inhibitorsSára Ferková, Matthieu Lepage, Antoine Désilets, et al.
Journal of Medicinal Chemistry|March 31, 2025
From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 VariantsGabriel Lemieux, Jimena Pérez-Vargas, Antoine Désilets, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|December 5, 2025
Structure-Guided Optimization of Selective Covalent Reversible Peptidomimetic Inhibitors Targeting TMPRSS6Walid Guerrab, Matthieu Lepage, Antoine Désilets, et al.
European Journal of Medicinal Chemistry|November 7, 2025
Structural insights into frog skin-derived cyclic peptides as selective matriptase inhibitorsAgata Gitlin-Domagalska, Malihe Hassanzadeh, Aleksandra Helbik-Maciejewska, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 20, 2025
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potencyAlexandre Joushomme, Antoine Désilets, William Champagne, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potencyAlexandre Joushomme, Antoine Désilets, William Champagne, et al.
Journal of Medicinal Chemistry|July 19, 2024
Rational <i>In Silico</i> Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 SubpocketMichael Desgagné, Antoine Désilets, Sára Ferková, et al.
European Journal of Medicinal Chemistry|May 18, 2025
Optimizing the pharmacokinetics and selectivity of TMPRSS2 inhibitorsSára Ferková, Matthieu Lepage, Antoine Désilets, et al.
Journal of Medicinal Chemistry|March 31, 2025
From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 VariantsGabriel Lemieux, Jimena Pérez-Vargas, Antoine Désilets, et al.
Pageof 1